Clinical translation of silica nanoparticles
280 Citations•2021•
Taskeen Iqbal Janjua, Yuxue Cao, Chengzhong Yu
Preliminary results indicate the safety, efficacy and viability of silica nanoparticles under clinical scenarios, including oral drug delivery, diagnostics, plasmonic resonance and photothermal ablation therapy.
Abstract
Silica nanoparticles have entered clinical trials for a variety of biomedical applications, including oral drug delivery, diagnostics, plasmonic resonance and photothermal ablation therapy. Preliminary results indicate the safety, efficacy and viability of silica nanoparticles under these clinical scenarios.